Glenn Reicin
Glenn Reicin
businesses fact given growth optimistic outlook quarter remain strong test underlying view
Given that the longer-term outlook for CRM is strong and the fact that underlying growth in most other businesses is unchanged, we remain optimistic about the future. As such, we view this quarter as a test of faith.
changes demand device hospitals leverage medical purchasing reducing unlikely
We think it is unlikely that these changes will modify purchasing and demand characteristics of medical devices. Hospitals have traditionally had little leverage in reducing device costs.
company investors overly past react
We think investors will look past third-quarter guidance, as the company has historically been overly conservative, and react favorably to the quarter.
believe boston businesses earnings management power recovery regarding remain rhythm scientific
Boston Scientific still has much 'wood to chop' regarding the recovery of the company's cardiac rhythm management business...That said, we believe earnings power for businesses remain substantial.
continue large none pursue suspect
We suspect that J&J will continue to pursue acquisitions, but none as large as Guidant.
decisions engineers management physicians senior simply
Simply put, engineers were making decisions that senior management and physicians should have made.
expand markets opportunity
The opportunity to expand into other markets could be significant.
quarter relatively view
We view this as a relatively uneventful quarter for Abbott.
believe carefully critical manage
We believe it will be critical for BSX to carefully manage its interaction with the FDA.
changes procedures proposed related
The proposed changes ... related to cardiac procedures are dramatic.
believe completion found generally given justified market quarter reaction results strong
Overall, we found results in the quarter to be generally weak, but believe the strong market reaction was justified given the anticipated completion of the Guidant vascular acquisition.
agreement company expand opportunity
If the company can expand this agreement to other markets, the opportunity could be big.
clarity future goals greater growth regarding
Greater clarity regarding this transaction and future growth goals (without the Guidant acquisition) are needed,
cause companies device forgo future producing revenue
The device replacements will cause companies to forgo revenue producing replacement units in future years.